Showing results (301-310 of 315) with videos related to
Sort By:
Pageof 32
Journal of Gastroenterology and Hepatology|October 13, 2017
Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessmentDong Ii Park, Tadakazu Hisamatsu, Minhu Chen, et al.Intestinal Research|February 10, 2018
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: managementDong Il Park, Tadakazu Hisamatsu, Minhu Chen, et al.Intestinal Research|February 10, 2018
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessmentDong Il Park, Tadakazu Hisamatsu, Minhu Chen, et al.Nature Communications|May 4, 2024
Diet-omics in the Study of Urban and Rural Crohn disease Evolution (SOURCE) cohortTzipi Braun, Rui Feng, Amnon Amir, et al.Gut|May 12, 2019
Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinomaMan Liu, Jingying Zhou, Xiaoyu Liu, et al.Gut|February 20, 2024
Milk fat globule-epidermal growth factor 8 (MFGE8) prevents intestinal fibrosisSinan Lin, Jie Wang, Pranab K Mukherjee, et al.Journal of Gastroenterology and Hepatology|January 11, 2013
Gastroesophageal Reflux Disease Questionnaire (GerdQ) in real-world practice: a national multicenter survey on 8065 patientsYu Bai, Yiqi Du, Duowu Zou, et al.Nature Immunology|March 21, 2023
Epithelial Nlrp10 inflammasome mediates protection against intestinal autoinflammationDanping Zheng, Gayatree Mohapatra, Lara Kern, et al.Journal of Gastroenterology and Hepatology|January 22, 2024
The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter studyQianjun Zhuang, Aijun Liao, Qingling He, et al.Cell|January 21, 2025
Metagenome-informed metaproteomics of the human gut microbiome, host, and dietary exposome uncovers signatures of health and inflammatory bowel diseaseRafael Valdés-Mas, Avner Leshem, Danping Zheng, et al.Pageof 32